期刊文献+

超敏C反应蛋白在冠心病诊断中的应用价值 被引量:3

The value of high-sensitivity C-reactive protein in patients with coronary heart disease
下载PDF
导出
摘要 目的研究不同病情冠心病(CHD)患者血清超敏C反应蛋白(hs-CRP)水平的变化,评价hs-CRP在CHD诊断中的应用价值。方法应用日立7180生化分析仪测定hs-CRP水平;用HP2500彩色超声仪测定颈动脉内-中膜厚度(IMT);统计学分析采用t检验和多因素Logistic回归分析。结果CHD组hs-CRP水平和IMT显著高于对照组,2组结果分别为(5.64±1.83)、(0.89±0.51)mg/L;(1.62±0.35)、(0.83±0.21)mm(P<0.01),而且hs-CRP水平与IMT呈明显正相关(r=0.6278,P<0.01);稳定型心绞痛(SAP)、不稳定型心绞痛(UAP)和急性心肌梗死(AMI)组hs-CRP水平呈递增趋势,并且在AMI组和UAP组的表达明显高于SAP组(P<0.01);hs-CRP作为新的危险因素在CHD的病理过程中发挥着重要的作用。结论hs-CRP是CHD的危险因素之一;hs-CRP在CHD不同分组中呈规律性变化,提示hs-CRP检测对CHD的诊断及预后具有潜在的应用价值。 Objective To study the variation of serum high-sensitivity C-reactive protein (hs- CRP) level in patients with the different types of coronary heart disease (CHD), and to evaluate the value of hs-CRP in the clinical diagnosis of CHD. Methods HITACHI 71g0 automatic biochemitry analyzer was applied to measuring the serum hs-CRP level, and HP2500 type color Doppler ultrasound analyzer applied measuring the intima-media thickness (IMT) of carotid artery for all subjects. The results were analyzed with statistical methods, including t test and multiple factor Logistic regression analysis. Results The serum level of hs-CRP and 1MT were significantly higher in CHD group than those of control group (5.64±1.83 vs 0. 89±0.51 mg/L,P〈0. 01;1. 62±0. 35 vs 0. 83±0.21 mm,P 〈0.01 respectively), and the serum level of hs-CRP was positively correlative to that of IMT (r=0. 627 8,P〈0.01) ; the serum hs-CRP level was elevated step by step following the stable angina pectoris (SAP), the unstable angina pectoris (UAP) to the acute myocardial infarction (AMI), and the serum hs-CRP level was significantly higher in AMI group and UAP group than that of SAP group; the serum hs-CRP might be a new and important risk factor for carotid atherosclerosis during the development of CHD. Conclusion hs-CRP is one of the risk factors for coronary heart disease; the serum hs-CRP level is related with the different types of CHD, which suggests that measurement of hsCRP contributes to diagnosis and prognosis evaluation of CHD.
出处 《国际检验医学杂志》 CAS 2008年第3期200-202,共3页 International Journal of Laboratory Medicine
关键词 C反应蛋白质 冠状动脉疾病 临床实验室技术 C-reactive protein Coronary disease Clinical laboratory techniques
  • 相关文献

参考文献7

  • 1Li JJ, Fang CH. C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular diseases [J]. Med Hypotheses, 2004, 62(4): 499-506. 被引量:1
  • 2Libby P. Inflammation in atheroselerosis [J]. Nature, 2002, 420 (6917) : 868-874. 被引量:1
  • 3Arroyo-Espliguero R, Avanzas P, Cosin Sales J, et al. C-reactive protein elevation and disease activity in patients with coronary arterydisease[J]. Eur Heart J, 2004, 25(5): 401-408. 被引量:1
  • 4Magadle R, Weiner P, Beckerman M, et al. C-reactive protein as a marker for active coronary artery disease in patients with chest pain in the emergency room [J]. Clin Cardiol, 2002, 25(10): 456-460. 被引量:1
  • 5Yamaguchi H, Homma Y, Handa S. Biochemical markers of vasospastie coronary artery disease[J]. Nutr Metab Cardiovase Dis, 2003, 13(6): 365-371. 被引量:1
  • 6杨好意,乐桂蓉.高分辨力超声评价高血压病患者外周动脉早期动脉粥样硬化[J].中华超声影像学杂志,2000,9(10):632-634. 被引量:43
  • 7Pasceri V, Cheng JS, Willerson JT, et al. Modulation of C-reactive protein medialed monocyle chemoattractant protein 1 induction in human endothelial cells by anti-atheroselerosis drugs[J]. Circulation, 2001, 103(21): 2531-2534. 被引量:1

二级参考文献5

  • 1Kimura Y,Can J Cardiol,1999年,15卷,563页 被引量:1
  • 2Deng Y B,Clin Cardiol,1999年,22卷,171页 被引量:1
  • 3Li J,Int J Cardiol,1997年,61卷,165页 被引量:1
  • 4Pearson A C,Am Heart J,1994年,128期,344页 被引量:1
  • 5Wong M,Arterioscler Thromb,1993年,13卷,482页 被引量:1

共引文献42

同被引文献18

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部